Post-translational modification of bone morphogenetic protein-1 is required for secretion and stability of the protein

被引:42
作者
Garrigue-Antar, L [1 ]
Hartigan, N [1 ]
Kadler, KE [1 ]
机构
[1] Univ Manchester, Sch Biol Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England
关键词
D O I
10.1074/jbc.M207342200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone morphogenetic protein (BMP)-1 is a glycosylated metalloproteinase that is fundamental to the synthesis of a normal extracellular matrix because it cleaves type I procollagen, as well as other precursor proteins. Sequence analysis suggests that BMP-1 has six potential N-linked glycosylation sites (i.e. NXS/T) namely: Asn(91) (prodomain), Asn(142) (metalloproteinase domain), Asn(332) and Asn(363) (CUB1 domain), Asn(599) (CUB3 domain), and Asn(726) in the C-terminal-specific domain. In this study we showed that all these sites are N-glycosylated with complex-type oligosaccharides containing sialic acid, except Asn(726) presumably because proline occurs immediately C-terminal of threonine in the consensus sequence. Recombinant BMP-1 molecules lacking all glycosylation sites or the three CUB-specific sites were not secreted. BMP-1 lacking CUB glycosylation was translocated to the proteasome for degradation. BMP-1 molecules lacking individual glycosylation sites were efficiently secreted and exhibited full procollagen C-proteinase activity, but N332Q and N599Q exhibited a slower rate of cleavage. BMP-1 molecules lacking any one of the CUB-specific glycosylation sites were sensitive to thermal denaturation. The study showed that the glycosylation sites in the CUB domains of BMP-1 are important for secretion and stability of the molecule.
引用
收藏
页码:43327 / 43334
页数:8
相关论文
共 59 条
[1]   Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 γ2 chain [J].
Amano, S ;
Scott, IC ;
Takahara, K ;
Koch, M ;
Champliaud, MF ;
Gerecke, DR ;
Keene, DR ;
Hudson, DL ;
Nishiyama, T ;
Lee, S ;
Greenspan, DS ;
Burgeson, RE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22728-22735
[2]   THE CUB DOMAIN - A WIDESPREAD MODULE IN DEVELOPMENTALLY-REGULATED PROTEINS [J].
BORK, P ;
BECKMANN, G .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 231 (02) :539-545
[3]   Characterization of the glycosylation profiles of Alzheimer's β-secretase protein Asp-2 expressed in a variety of cell lines [J].
Charlwood, J ;
Dingwall, C ;
Matico, R ;
Hussain, I ;
Johanson, K ;
Moore, S ;
Powell, DJ ;
Skehel, JM ;
Ratcliffe, S ;
Clarke, B ;
Trill, J ;
Sweitzer, S ;
Camilleri, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :16739-16748
[4]   The C-terminal N-glycosylation sites of the human α1,3/4-fucosyltransferase III, -V, and -VI (hFucTIII, -V and -VI) are necessary for the expression of full enzyme activity [J].
Christensen, LL ;
Jensen, UB ;
Bross, P ;
Orntoft, TF .
GLYCOBIOLOGY, 2000, 10 (09) :931-939
[5]  
DUMERMUTH E, 1991, J BIOL CHEM, V266, P21381
[6]   GLYCOSIDASE INHIBITORS - INHIBITORS OF N-LINKED OLIGOSACCHARIDE PROCESSING [J].
ELBEIN, AD .
FASEB JOURNAL, 1991, 5 (15) :3055-3063
[7]  
ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497
[8]   Lactacystin, proteasome function, and cell fate [J].
Fenteany, G ;
Schreiber, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :8545-8548
[9]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[10]  
FINELLI L, 1995, GENETICS, V141, P271